TELMISARTAN AND HYDROCHLOROTHIAZIDE
MANKIND PHARMA · HYDROCHLOROTHIAZIDE, TELMISARTAN
Open FDA's page for this record- Application number
- ANDA218406
- Sponsor name
- MANKIND PHARMA
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20250303
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 002
- Reference drug
- No
- Brand name
- TELMISARTAN AND HYDROCHLOROTHIAZIDE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Te code
- AB
- Active ingredients
- Name
- HYDROCHLOROTHIAZIDE
- Strength
- 12.5MG
- Name
- TELMISARTAN
- Strength
- 80MG
- Product number
- 003
- Reference drug
- No
- Brand name
- TELMISARTAN AND HYDROCHLOROTHIAZIDE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Te code
- AB
- Active ingredients
- Name
- HYDROCHLOROTHIAZIDE
- Strength
- 25MG
- Name
- TELMISARTAN
- Strength
- 80MG
- Product number
- 001
- Reference drug
- No
- Brand name
- TELMISARTAN AND HYDROCHLOROTHIAZIDE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Te code
- AB
- Active ingredients
- Name
- HYDROCHLOROTHIAZIDE
- Strength
- 12.5MG
- Name
- TELMISARTAN
- Strength
- 40MG
- Harmonized identifiers (openFDA)
- Application number
- ANDA218406
- Brand name
- TELMISARTAN AND HYDROCHLOROTHIAZIDE
- Generic name
- TELMISARTAN AND HYDROCHLOROTHIAZIDE
- Manufacturer name
- Lifestar Pharma LLC
- Product NDC
- 70756-315, 70756-316, 70756-317
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- TELMISARTAN, HYDROCHLOROTHIAZIDE
- RxCUI
- 283316, 283317, 477130
- SPL ID
- 70efda7e-0c71-4faf-be4e-ef281d7cc297
- SPL set ID
- 0c1bd0f4-034e-486c-ae46-2855c8c9ebda
- Package NDC
- 70756-315-30, 70756-315-31, 70756-315-99, 70756-316-30, 70756-316-99, 70756-316-31, 70756-317-30, 70756-317-99, 70756-317-31
- Nui
- N0000000070, N0000175561, N0000175359, N0000175419, M0471776
- Pharm class moa
- Angiotensin 2 Receptor Antagonists [MoA]
- Pharm class epc
- Angiotensin 2 Receptor Blocker [EPC], Thiazide Diuretic [EPC]
- Pharm class pe
- Increased Diuresis [PE]
- Pharm class cs
- Thiazides [CS]
- UNII
- U5SYW473RQ, 0J48LPH2TH
